HTML

Standardising practices through form design and education improves insulin management
Fiona B McIver, Charles A Mitchell, Carmel P Finn and Maarten C Kamp — Aust Health Rev 2009; 33 (3): 434-441.

HTML

A review of proposals to reform the regulation of complementary medicines
Ken J Harvey — Aust Health Rev 2009; 33 (2): 279-287.

HTML

Doctor and pharmacist — back to the apothecary!
Siaw-Teng Liaw and Gregory Peterson — Aust Health Rev 2009; 33 (2): 268-278.

HTML

Policy challenges of nanomedicine for Australia’s PBS
Thomas A Faunce — Aust Health Rev 2009; 33 (2): 258-267.

HTML

Biopharmaceutical innovation and industrial developments in South Korea, Singapore and Taiwan
Chee-Ruey Hsieh and Hans Löfgren — Aust Health Rev 2009; 33 (2): 245-257.

HTML

PBS copayments and safety nets
Ruth Lopert — Aust Health Rev 2009; 33 (2): 241-244.

HTML

Transparency in pricing arrangements for medicines listed on the Australian Pharmaceutical Benefits Scheme
Jane Robertson, Emily J Walkom and David A Henry — Aust Health Rev 2009; 33 (2): 192-199.

HTML

The PBS in a globalised world: free trade and reference pricing
Andrew Searles — Aust Health Rev 2009; 33 (2): 186-191.

HTML

The economic crisis, the Pharmaceutical Benefits Scheme, and the dilemmas of medicines policy
Hans Löfgren — Aust Health Rev 2009; 33 (2): 171-175.

HTML

It’s not the evidence, it’s the way you use it: is clinical practice being tyrannised by evidence?
Kathy Stiller — Aust Health Rev 2008; 32 (2): 204-207.

HTML

Towards a socio-political understanding of the pharmaceutical sector
Hans Lofgren — Aust Health Rev 2004; 28 (2): 147-149.

HTML

Pharmaceuticals, the state and the global harmonisation process
John Abraham — Aust Health Rev 2004; 28 (2): 150-160.

HTML

Catching up in pharmaceuticals: government policies and the rise of genomics
Mats Benner — Aust Health Rev 2004; 28 (2): 161-170.

HTML

Tough but fair"? The active management of the New Zealand drug benefits scheme by an independent Crown agency
Peter Davis — Aust Health Rev 2004; 28 (2): 171-181.

HTML

India’s pharmaceutical industry: hype or high tech take-off?
Prabodh Malhotra and Hans Lofgren — Aust Health Rev 2004; 28 (2): 182-193.

HTML

The subsidy of pharmaceuticals in Australia: processes and challenges
Lloyd Sansom — Aust Health Rev 2004; 28 (2): 194-205.

HTML

Some drugs more equal than others: pseudo-generics and commercial practice
Andrew J Probyn — Aust Health Rev 2004; 28 (2): 207-217.

HTML

Patents, pills and politics: the Australia–United States Free Trade Agreement and the Pharmaceutical Benefits Scheme
Ken Harvey — Aust Health Rev 2004; 28 (2): 218-226.

HTML

Pharmaceuticals and the consumer movement: the ambivalences of ‘patient power’
Hans Lofgren — Aust Health Rev 2004; 28 (2): 228-237.

HTML

Community pharmacy in Australia
Shalom I Benrimoj and Michael S Frommer — Aust Health Rev 2004; 28 (2): 238-246.